REG - Inspecs Group PLC - Result of AGM

InspecsAnnouncement

11/08/2022 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220811:nRSK7632Va&default-theme=true

RNS Number : 7632V  Inspecs Group PLC  11 August 2022

11 August 2022

Inspecs Group plc

("Inspecs" the "Company" or "the Group")

Result of AGM

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear
frames, announces that at the Annual General Meeting held earlier today, all
resolutions were duly passed.

 

 Resolution                                                                               For                          Against                      Withheld    Total votes cast
         Number of                                                                        %           Number of votes  %           Number of votes

         votes
 1.      Ordinary resolution to receive and adopt the Company's annual accounts and       74,283,217  86.36%           11,730,789  13.64%           2,918,304   88,932,310
         reports
 2.      Ordinary resolution to declare a final dividend                                  88,932,210  100.00%          100         0.00%            0           88,932,310
 3.      Ordinary resolution to re-elect Lord MacLaurin as a director of the Company.     70,273,568  90.69%           7,211,334   9.31%            11,447,408  88,932,310
 4.      Ordinary resolution to re-elect Robin Totterman as a director of the Company.    88,932,065  100.00%          245         0.00%            0           88,932,310
 5.      Ordinary resolution to re-elect Christopher Kay as a director of the Company.    88,235,979  99.22%           696,231     0.78%            100         88,932,310

 6.      Ordinary resolution to re-elect Christopher Hancock as a director of the         67,757,305  82.13%           14,739,869  17.87%           6,435,136   88,932,310

       Company.

 7.      Ordinary resolution to re-elect Richard Peck as a director of the Company.       68,126,562  82.58%           14,370,612  17.42%           6,435,136   88,932,310

 8.      Ordinary resolution to re-elect Angela Farrugia as a director of the Company.    82,242,520  96.48%           3,004,273   3.52%            3,685,517   88,932,310

 9.      Ordinary resolution to re-appoint Ernst & Young LLP as the Company's             88,932,310  100.00%          0           0.00%            0           88,932,310
         auditors to hold office from the conclusion of this meeting until the
         conclusion of the next meeting, in accordance with normal practice.
 10.     Ordinary resolution to authorise the directors to determine the remuneration     88,932,310  100.00%          0           0.00%            0           88,932,310
         of the auditors
 11.     Ordinary resolution to enable the Company and each of its subsidiaries to make   87,095,027  99.33%           587,995     0.67%            1,249,288   88,932,310

       political donations and expenditure.

 12.     Ordinary resolution to authorise the directors to allot ordinary shares in the   88,932,065  100.00%          245         0.00%            0           88,932,310
         Company up to a maximum nominal amount of £338,905.08 and up to a further

         maximum nominal amount of £338,905.08 where the allotment is in connection
         with an offer by way of a rights issue.
 13.     Special resolution to enable the directors to allot, grant options over or       87,682,777  98.60%           1,249,283   1.40%            250         88,932,310
         otherwise dispose of equity securities for cash or sell treasury shares for
         cash up to a maximum aggregate nominal amount of £50,835.76 as if pre-emption
         rights did not apply to such allotment.
 14.     Special Resolution to further disapply pre-emption rights in relation to         87,682,777  98.60%           1,249,283   1.40%            250         88,932,310
         acquisitions or other capital investments.
 15.     Special resolution to authorise the Company to make market purchases of up to    88,932,065  100.00%          245         0.00%            0           88,932,310
         10,167,153 ordinary shares (which represents approximately 10 per cent of the
         Company's ordinary shares (excluding treasury shares) in issue on 31 December
         2021).

 

 

For further information please contact:

 

 Inspecs Group plc                         via FTI Consulting

 Robin Totterman (CEO)                     Tel: +44 (0) 20 3727 1000

 Chris Kay (CFO)

 Peel Hunt (Nominated Adviser and Broker)  Tel: +44 (0) 20 7418 8900

 Adrian Trimmings

 Andrew Clark

 Lalit Bose

 FTI Consulting (Financial PR)             Tel: +44 (0) 20 3727 1000

 Alex Beagley

 Harriet Jackson

 Alice Newlyn

About Inspecs Group plc

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear
frames and optically advanced spectacle lenses. The Group produces a broad
range of frames and lenses, covering optical, sunglasses and safety, which are
either "Branded" (either under licence or under the Group's own proprietary
brands), or "OEM" (including private label on behalf of retail customers and
un-branded).

INSPECS aims to be the leader in eyewear solutions through its
vertically-integrated business model and has adopted a three pillar growth
strategy to achieve this: (i) continue to grow organically; (ii) undertake
further acquisitions (and drive value through leveraging the Group's internal
capabilities); and (iii) extend the Group's manufacturing capacity.

 The Group has completed a number of significant acquisitions since its IPO
in February 2020. In December 2020, INSPECS acquired Eschenbach, a leading
global eyewear supplier, headquartered in Nuremberg, Germany, which includes
the American company Tura. This followed the acquisition of lens maker
Norville in July 2020, whereby INSPECS combined two heritage brands in British
optical, Savile Row frame maker, and Norville lens maker, further enhancing
its vertically integrated business model. In December 2021 the Group acquired
Ego Eyewear, a design and licensing company which uses third party eyewear
manufacturers to produce premium fashion brands, and BoDe, a distributor of
optical and sunglasses frames principally to the German market.

INSPECS customers include global optical and non-optical retailers, global
distributors and independent opticians, with its distribution network covering
over 80 countries and reaching approximately 75,000 points of sale.

INSPECS has operations across the globe: with offices in the UK, Portugal,
Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and
manufacturing facilities in Vietnam, China, the UK and Italy. With the
acquisition of Eschenbach, the Group's international reach further extends
across Europe and the American markets.

 

More information is available at: https://inspecs.com (https://inspecs.com)
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPBMITMTTBBPT